
Novo
Novo is a Danish pharmaceutical company. It was founded in 1923 by Hans Christian Hagedorn, August Krogh and Marie Krogh. Its headquarters are in Bagsværd. Its chief executive is Lars Fruergaard Jørgensen. It has 69,505 employees (2025).
- Founded
- 1923
- Founded by
- Hans Christian Hagedorn
- Headquarters
- Bagsværd
- Industry
- pharmaceutical industry
- Chief executive
- Lars Fruergaard Jørgensen (2017–)
- Employees
- 69,505 (2025)
All 18 facts, and where they come from
Facts
18 facts · 0 confirmed by two sources · 5 cited · 13 from one source
Where this comes from
Papalocal keeps its own record. It started from these sources; what each one said is kept here as it was copied, so a change on their side never changes this page by itself. Tap one to read its version.
What Wikidata says · copied November 17, 2026 · revision 2563129192
- Described as
- Danish pharmaceutical company
- Other names
- Novo Nordisk, Novo Nordisk A/S
- What it is
- business; enterprise; public company · 1 reference
- Founded
- 1923
- Founded by
- Hans Christian Hagedorn; August Krogh; Marie Krogh; August Kongsted
- Headquarters
- Bagsværd
- Country
- Denmark · 1 reference
- Industry
- pharmaceutical industry
- Chief executive
- Lars Fruergaard Jørgensen (2017–) · 1 reference; Lars Rebien Sørensen (2000–2016) · 2 references
- Employees
- 42 (2016) · 1 reference
- Part of
- Novo Holdings
- Owned by
- Novo Holdings (2023) · 1 reference; Novo Nordisk Foundation (2023) · 1 reference
- Official website
- https://www.novonordisk.com
- Wikipedias with a page
- 35
Wikidata item Q818846 (wikidata.org/wiki/Q818846), public domain (CC0). Copied 2026-11-17.
What Wikipedia says · copied November 17, 2026 · revision 1384989738
Novo Nordisk A/S, doing business as Novo, is a Danish multinational pharmaceutical company. Novo manufactures and markets pharmaceutical products and services, primarily obesity and diabetes medications and devices. The corporation was created in 1989, through a merger of two Danish pharmaceutical companies, which date back to the 1920s.
Novo employs approximately 69,500 people in 80 countries, and markets its products in approximately 170 countries. Novo is controlled by majority shareholder Novo Holdings (wholly owned by the Novo Nordisk Foundation) which holds 28% of its shares and a majority (77%) of its voting shares.
Novo is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA).
The company was ranked 25th among Fortune's 100 Best Companies to Work For in 2010, and subsequently ranked 72nd in 2014 and 73rd in 2017. In January 2012, Novo was named the most sustainable company in the world by the business magazine Corporate Knights. It is a leader in the FTSE4Good Index, and the only European company in the top ten.
Novo is the largest pharmaceutical company in Denmark. In 2023, Novo's market capitalization exceeded the GDP of Denmark, and it became the highest valued company in Europe.
From the Wikipedia article “Novo (company)” (en.wikipedia.org/wiki/Novo_(company)), by its contributors, under CC BY-SA 4.0 (creativecommons.org/licenses/by-sa/4.0/). Copied 2026-11-17; not changed.
Confirmed Two sources agree. Cited One source, and it names where it got it. One source One source, without a reference of its own. Sources disagree The sources disagree. We show the best-supported value and keep theirs below.
Picture: News Øresund - Johan Wessman, via Wikimedia Commons · CC BY 3.0
